{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:42:06Z","timestamp":1793752926837,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["FI-DGR"],"award-info":[{"award-number":["FI-DGR"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["FI-DGR"],"award-info":[{"award-number":["FI-DGR"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["2017SGR1508"],"award-info":[{"award-number":["2017SGR1508"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","award":["ICREA Academia Award"],"award-info":[{"award-number":["ICREA Academia Award"]}],"id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005051","name":"MPS Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mucopolysaccharidosis type IVA (MPSIVA) or Morquio A disease, a lysosomal storage disorder, is caused by<jats:italic>N<\/jats:italic>-acetylgalactosamine-6-sulfate sulfatase (GALNS) deficiency, resulting in keratan sulfate (KS) and chondroitin-6-sulfate accumulation. Patients develop severe skeletal dysplasia, early cartilage deterioration and life-threatening heart and tracheal complications. There is no cure and enzyme replacement therapy cannot correct skeletal abnormalities. Here, using CRISPR\/Cas9 technology, we generate the first MPSIVA rat model recapitulating all skeletal and non-skeletal alterations experienced by patients. Treatment of MPSIVA rats with adeno-associated viral vector serotype 9 encoding<jats:italic>Galns<\/jats:italic>(AAV9-<jats:italic>Galns<\/jats:italic>) results in widespread transduction of bones, cartilage and peripheral tissues. This led to long-term (1 year) increase of GALNS activity and whole-body correction of KS levels, thus preventing body size reduction and severe alterations of bones, teeth, joints, trachea and heart. This study demonstrates the potential of AAV9-<jats:italic>Galns<\/jats:italic>gene therapy to correct the disabling MPSIVA pathology, providing strong rationale for future clinical translation to MPSIVA patients.<\/jats:p>","DOI":"10.1038\/s41467-021-25697-y","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T10:05:22Z","timestamp":1631181922000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Treatment of skeletal and non-skeletal alterations of Mucopolysaccharidosis type IVA by AAV-mediated gene therapy"],"prefix":"10.1038","volume":"12","author":[{"given":"Joan","family":"Bertolin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edctor","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7120-4276","authenticated-orcid":false,"given":"Albert","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9188-0810","authenticated-orcid":false,"given":"Maria Luisa","family":"Ja\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miquel","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0897-0661","authenticated-orcid":false,"given":"Xavier","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3502-5198","authenticated-orcid":false,"given":"Sara","family":"Marc\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Roca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Otaegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9584-4211","authenticated-orcid":false,"given":"Francisca","family":"Mulero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Ruberte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7705-5515","authenticated-orcid":false,"given":"Fatima","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"25697_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1172\/JCI108345","volume":"57","author":"J Singh","year":"1976","unstructured":"Singh, J., Ferrante, N., Di, Niebes, P. & Tavella, D. N-acetylgalactosamine-6-sulfate sulfatase in man. J. Clin. Invest. 57, 1036\u20131040 (1976).","journal-title":"J. Clin. Invest."},{"key":"25697_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.2174\/138920111795542615","volume":"12","author":"S Tomatsu","year":"2011","unstructured":"Tomatsu, S. et al. Mucopolysaccharidosis type IVA (Morquio A Disease): clinical review and current treatment: a special review. Curr. Pharm. Biotechnol. 12, 931\u2013945 (2011).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"25697_CR3","unstructured":"Tomatsu, S. et al. Morquio A syndrome: diagnosis and current and future therapies. Pediatr. Endocrinol. Rev. 12, 141\u2013151 (2014)."},{"key":"25697_CR4","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ymgme.2017.12.047","volume":"123","author":"S Byers","year":"2018","unstructured":"Byers, S., Vaidyanathan, S., L.K, A. & S.A, D.-R. Chondrogenesis and osteogenesis are delayed by MPS IVA keratan sulphate but not normal keratan sulphate. Mol. Genet. Metab. 123, 174 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o, A. M., Tomatsu, S., Gottesman, G. S., Smith, M. & Orii, T. International Morquio A Registry: Clinical manifestation and natural course of Morquio A disease. J. Inherit. Metab. Dis. 30, 165\u2013174 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"25697_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF01799267","volume":"19","author":"H Northover","year":"1996","unstructured":"Northover, H., Cowie, R. A. & Wraith, J. E. Mucopolysaccharidosis type IVA (Morquio syndrome): a clinical review. J. Inherit. Metab. Dis. 19, 357\u2013365 (1996).","journal-title":"J. Inherit. Metab. Dis."},{"key":"25697_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/humu.20257","volume":"26","author":"S Tomatsu","year":"2005","unstructured":"Tomatsu, S. et al. Mutation and polymorphism spectrum of the GALNS gene in mucopolysaccharidosis IVA (Morquio A). Hum. Mutat. 26, 500\u2013512 (2005).","journal-title":"Hum. Mutat."},{"key":"25697_CR8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymgme.2013.06.008","volume":"110","author":"VC D\u0169ng","year":"2013","unstructured":"D\u0169ng, V. C. et al. Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels. Mol. Genet. Metab. 110, 129\u2013138 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/(SICI)1098-1004(1996)7:2<123::AID-HUMU6>3.0.CO;2-D","volume":"7","author":"S Fukuda","year":"1996","unstructured":"Fukuda, S. et al. Mucopolysaccharidosis IVA: Submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical morquio disease. Hum. Mutat. 7, 123\u2013134 (1996).","journal-title":"Hum. Mutat."},{"key":"25697_CR10","first-page":"59","volume":"15","author":"C Lavery","year":"2014","unstructured":"Lavery, C. & Hendriksz, C. Mortality in patients with Morquio syndrome A. JIMD Rep. 15, 59\u201366 (2014).","journal-title":"JIMD Rep."},{"key":"25697_CR11","first-page":"139","volume":"176","author":"J Yangzi","year":"2015","unstructured":"Yangzi, J. & Tuan, R. S. Origin and function of cartilage stem\/progenitor cells in osteoarthritis. Physiol. Behav. 176, 139\u2013148 (2015).","journal-title":"Physiol. Behav."},{"key":"25697_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13018-017-0534-y","volume":"12","author":"A Goldberg","year":"2017","unstructured":"Goldberg, A., Mitchell, K., Soans, J., Kim, L. & Zaidi, R. The use of mesenchymal stem cells for cartilage repair and regeneration: a systematic review. J. Orthop. Surg. Res. 12, 1\u201330 (2017).","journal-title":"J. Orthop. Surg. Res."},{"key":"25697_CR13","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/mt.2010.32","volume":"18","author":"S Tomatsu","year":"2010","unstructured":"Tomatsu, S. et al. Enhancement of drug delivery: enzyme-replacement therapy for murine morquio a syndrome. Mol. Ther. 18, 1094\u20131102 (2010).","journal-title":"Mol. Ther."},{"key":"25697_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s10038-019-0604-6","volume":"64","author":"C Doherty","year":"2019","unstructured":"Doherty, C. et al. Effect of enzyme replacement therapy on the growth of patients with Morquio A. J. Hum. Genet. 64, 625\u2013635 (2019).","journal-title":"J. Hum. Genet."},{"key":"25697_CR15","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s40265-014-0210-z","volume":"74","author":"M Sanford","year":"2014","unstructured":"Sanford, M. & Lo, J. H. Elosulfase alfa: first global approval. Drugs 74, 713\u2013718 (2014).","journal-title":"Drugs"},{"key":"25697_CR16","first-page":"S144","volume":"126","author":"S Tomatsu","year":"2019","unstructured":"Tomatsu, S., Doherty, C. & Stapleton, M. Effect of enzyme replacement therapy on the growth of patients with Morquio syndrome type A. Mol. Genet. Metab. 126, S144 (2019).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR17","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1007\/s10545-014-9715-6","volume":"37","author":"CJ Hendriksz","year":"2014","unstructured":"Hendriksz, C. J. et al. Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo-controlled study. J. Inherit. Metab. Dis. 37, 979\u2013990 (2014).","journal-title":"J. Inherit. Metab. Dis."},{"key":"25697_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ymgme.2014.08.012","volume":"114","author":"CJ Hendriksz","year":"2015","unstructured":"Hendriksz, C. J. et al. Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial. Mol. Genet. Metab. 114, 178\u2013185 (2015).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrg2988","volume":"12","author":"F Mingozzi","year":"2011","unstructured":"Mingozzi, F. & High, K. A. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges. Nat. Rev. Genet. 12, 341\u2013355 (2011).","journal-title":"Nat. Rev. Genet."},{"key":"25697_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nature15818","volume":"526","author":"L Naldini","year":"2015","unstructured":"Naldini, L. Gene therapy returns to centre stage. Nature 526, 351\u2013360 (2015).","journal-title":"Nature"},{"key":"25697_CR21","doi-asserted-by":"crossref","unstructured":"Marc\u00f3, S., Haurigot, V. & Bosch, F. In vivo gene therapy for Mucopolysaccharidosis type III (Sanfilippo syndrome): a new treatment horizon. Hum. Gene Ther. 30, 1211\u20131221 (2019).","DOI":"10.1089\/hum.2019.217"},{"key":"25697_CR22","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1093\/hmg\/ddg366","volume":"12","author":"S Tomatsu","year":"2003","unstructured":"Tomatsu, S. et al. Mouse model on N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns\u2212\/\u2212) produced by targeted disruption of the gene defective in Morquio A disease. Hum. Mol. Genet. 12, 3349\u20133358 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"25697_CR23","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1093\/hmg\/ddi364","volume":"14","author":"S Tomatsu","year":"2005","unstructured":"Tomatsu, S. et al. Development of MPS IVA mouse (Galnstm(hC79S\u00b7mC76S)slu) tolerant to human N-acetylgalactosamine-6-sulfate sulfatase. Hum. Mol. Genet. 14, 3321\u20133335 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"25697_CR24","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ymgme.2007.02.009","volume":"91","author":"S Tomatsu","year":"2007","unstructured":"Tomatsu, S. et al. Murine model (Galnstm(C76S)slu) of MPS IVA with missense mutation at the active site cysteine conserved among sulfatase proteins. Mol. Genet. Metab. 91, 251\u2013258 (2007).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR25","first-page":"50","volume":"18","author":"K Sawamoto","year":"2020","unstructured":"Sawamoto, K. et al. Liver-targeted AAV8 gene therapy ameliorates skeletal and cardiovascular pathology in a Mucopolysaccharidosis IVA murine model. Mol. Ther. 18, 50\u201361 (2020).","journal-title":"Mol. Ther."},{"key":"25697_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.mt.6300325","volume":"16","author":"A Tessitore","year":"2008","unstructured":"Tessitore, A. et al. Biochemical, pathological, and skeletal improvement of mucopolysaccharidosis VI after gene transfer to liver but not to muscle. Mol. Ther. 16, 30\u201337 (2008).","journal-title":"Mol. Ther."},{"key":"25697_CR27","doi-asserted-by":"crossref","unstructured":"Larcher, T. et al. Characterization of dystrophin deficient rats: a new model for duchenne muscular dystrophy. PLoS ONE 9, e110371 (2014).","DOI":"10.1371\/journal.pone.0110371"},{"key":"25697_CR28","first-page":"1169","volume":"9","author":"LJ Lambert","year":"2016","unstructured":"Lambert, L. J. et al. Increased trabecular bone and improved biomechanics in an osteocalcin-null rat model created by CRISPR\/Cas9. Technol. DMM Dis. Model. Mech. 9, 1169\u20131179 (2016).","journal-title":"Technol. DMM Dis. Model. Mech."},{"key":"25697_CR29","first-page":"1139","volume":"9","author":"SA Hansen","year":"2016","unstructured":"Hansen, S. A. et al. Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis. DMM Dis. Model. Mech. 9, 1139\u20131146 (2016).","journal-title":"DMM Dis. Model. Mech."},{"key":"25697_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1242\/dmm.026435","volume":"9","author":"ACY Yau","year":"2016","unstructured":"Yau, A. C. Y. & Holmdahl, R. Rheumatoid arthritis: identifying and characterising polymorphisms using rat models. DMM Dis. Model. Mech. 9, 1111\u20131123 (2016).","journal-title":"DMM Dis. Model. Mech."},{"key":"25697_CR31","doi-asserted-by":"publisher","first-page":"290","DOI":"10.21037\/atm.2019.05.56","volume":"7","author":"BJ Byrne","year":"2019","unstructured":"Byrne, B. J. et al. Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy. Ann. Transl. Med. 7, 290 (2019).","journal-title":"Ann. Transl. Med."},{"key":"25697_CR32","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nmeth.3408","volume":"12","author":"V Iyer","year":"2015","unstructured":"Iyer, V. et al. Off-target mutations are rare in Cas9-modified mice. Nat. Methods 12, 479 (2015).","journal-title":"Nat. Methods"},{"key":"25697_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1262\/jrd.2018-128","volume":"65","author":"S Ayabe","year":"2019","unstructured":"Ayabe, S., Nakashima, K. & Yoshiki, A. Off- and on-target effects of genome editing in mouse embryos. J. Reprod. Dev. 65, 1\u20135 (2019).","journal-title":"J. Reprod. Dev."},{"key":"25697_CR34","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1007\/s10545-007-0702-z","volume":"30","author":"AM Monta\u00f1o","year":"2007","unstructured":"Monta\u00f1o, A. M. et al. Effect of \u2018attenuated\u2019 mutations in mucopolysaccharidosis IVA on molecular phenotypes of N-acetylgalactosamine-6-sulfate sulfatase. J. Inherit. Metab. Dis. 30, 758\u2013767 (2007).","journal-title":"J. Inherit. Metab. Dis."},{"key":"25697_CR35","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.2337\/db13-0311","volume":"62","author":"V Jimenez","year":"2013","unstructured":"Jimenez, V. et al. In vivo adeno-associated viral vector-mediated genetic engineering of white and brown adipose tissue in adult mice. Diabetes 62, 4012\u20134022 (2013).","journal-title":"Diabetes"},{"key":"25697_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201708791","volume":"10","author":"V Jimenez","year":"2018","unstructured":"Jimenez, V. et al. FGF21 gene therapy as treatment for obesity and insulin resistance. EMBO Mol. Med. 10, 1\u201324 (2018).","journal-title":"EMBO Mol. Med."},{"key":"25697_CR37","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41366-020-00700-6","volume":"45","author":"E Casana","year":"2020","unstructured":"Casana, E. et al. BMP7 overexpression in adipose tissue induces white adipogenesis and improves insulin sensitivity in ob\/ob mice. Int. J. Obes. 45, 449\u2013460 (2020).","journal-title":"Int. J. Obes."},{"key":"25697_CR38","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/hmg\/ddu727","volume":"24","author":"A Ribera","year":"2015","unstructured":"Ribera, A. et al. Biochemical, histological and functional correction of mucopolysaccharidosis Type IIIB by intra-cerebrospinal fluid gene therapy. Hum. Mol. Genet. 24, 2078\u20132095 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"25697_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.86696","volume":"1","author":"S Motas","year":"2016","unstructured":"Motas, S. et al. CNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome). JCI Insight 1, 1\u201318 (2016).","journal-title":"JCI Insight"},{"key":"25697_CR40","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/hmg\/ddx058","volume":"26","author":"C Roca","year":"2017","unstructured":"Roca, C. et al. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID. Hum. Mol. Genet. 26, 1535\u20131551 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"25697_CR41","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1242\/dmm.025171","volume":"9","author":"S Marc\u00f3","year":"2016","unstructured":"Marc\u00f3, S. et al. Progressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC. DMM Dis. Model. Mech. 9, 999\u20131013 (2016).","journal-title":"DMM Dis. Model. Mech."},{"key":"25697_CR42","doi-asserted-by":"crossref","unstructured":"Fang-Kircher, S. G., Herkner, K., Windhager, R. & Lubec, G. The effects of acid glycosaminoglycans on neonatal calvarian cultures\u2014a role of keratan sulfate in morquio syndrome. Life Sci. 61, 771\u2013775 (1997).","DOI":"10.1016\/S0024-3205(97)00558-4"},{"key":"25697_CR43","doi-asserted-by":"publisher","first-page":"e240","DOI":"10.1016\/j.oooo.2015.08.009","volume":"120","author":"DJ De Santana Sarmento","year":"2015","unstructured":"De Santana Sarmento, D. J. et al. Mucopolysaccharidosis: radiographic findings in a series of 16 cases. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. 120, e240\u2013e246 (2015).","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol."},{"key":"25697_CR44","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s12306-016-0441-0","volume":"101","author":"D Colmenares-Bonilla","year":"2017","unstructured":"Colmenares-Bonilla, D., Vasconcelos-Martinez, M., Guerra-Jasso, J. & Ocampo-Perez, L. Guided growth may not be the best option for knee valgus deformity in adolescent patients with Morquio-A. Musculoskelet. Surg. 101, 113\u2013118 (2017).","journal-title":"Musculoskelet. Surg."},{"key":"25697_CR45","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.ymgme.2016.11.007","volume":"120","author":"S Khan","year":"2017","unstructured":"Khan, S. et al. Mucopolysaccharidosis IVA and glycosaminoglycans. Mol. Genet. Metab. 120, 78\u201395 (2017).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR46","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ymgme.2018.05.004","volume":"125","author":"H Peracha","year":"2018","unstructured":"Peracha, H. et al. Molecular genetics and metabolism, special edition: diagnosis, diagnosis and prognosis of Mucopolysaccharidosis IVA. Mol. Genet. Metab. 125, 18\u201337 (2018).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ymgme.2013.04.009","volume":"109","author":"E Yasuda","year":"2013","unstructured":"Yasuda, E. et al. Pathogenesis of Morquio A syndrome: an autopsied case reveals systemic storage disorder. Mol. Genet. Metab. 109, 301\u2013311 (2013).","journal-title":"Mol. Genet. Metab."},{"key":"25697_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0162612","volume":"11","author":"C Kampmann","year":"2016","unstructured":"Kampmann, C. et al. Heart and cardiovascular involvement in patients with mucopolysaccharidosis type IVA (Morquio-A syndrome). PLoS ONE 11, 1\u201312 (2016).","journal-title":"PLoS ONE"},{"key":"25697_CR49","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.joca.2007.04.008","volume":"15","author":"L De Franceschi","year":"2007","unstructured":"De Franceschi, L., Roseti, L., Desando, G., Facchini, A. & Grigolo, B. A molecular and histological characterization of cartilage from patients with Morquio syndrome. Osteoarthr. Cartil. 15, 1311\u20131317 (2007).","journal-title":"Osteoarthr. Cartil."},{"key":"25697_CR50","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1006\/geno.1995.9962","volume":"29","author":"T Kunieda","year":"1995","unstructured":"Kunieda, T. et al. Mucopolysaccharidosis type VI in rats: isolation of cDNAs encoding arylsulfatase B, chromosomal localization of the gene, and identification of the mutation. Genomics 29, 582\u2013587 (1995).","journal-title":"Genomics"},{"key":"25697_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1755-8417-2-4","volume":"2","author":"A Tessitore","year":"2009","unstructured":"Tessitore, A., Pirozzi, M. & Auricchio, A. Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI. Pathogenetics 2, 4 (2009).","journal-title":"Pathogenetics"},{"key":"25697_CR52","doi-asserted-by":"crossref","unstructured":"Guevara-Morales, J. M. et al. Growth plate pathology in the mucopolysaccharidosis type VI rat model-an experimental and computational approach. Diagnostics 10, 360 (2020).","DOI":"10.3390\/diagnostics10060360"},{"key":"25697_CR53","doi-asserted-by":"crossref","unstructured":"Forriol, F. & Shapiro, F. Bone development: interaction of molecular components and biophysical forces. Clin. Orthop. Relat. Res. 432, 14\u201333 (2005).","DOI":"10.1097\/01.blo.0000156001.78631.e9"},{"key":"25697_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison, S. J. & Scadden, D. T. The bone marrow niche for haematopoietic stem cells. Nature 505, 327\u2013334 (2014).","journal-title":"Nature"},{"key":"25697_CR55","doi-asserted-by":"crossref","unstructured":"Knothe, M. L., Adamson, J. R., Tami, A. E. & Bauer, T. W. The osteocyte. Int. J. Biochem. Cell Biol. 36, 1\u20138 (2004).","DOI":"10.1016\/S1357-2725(03)00241-3"},{"key":"25697_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/1759720X12448454","volume":"4","author":"MB Goldring","year":"2012","unstructured":"Goldring, M. B. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther. Adv. Musculoskelet. Dis. 4, 269\u2013285 (2012).","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"25697_CR57","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrrheum.2016.210","volume":"13","author":"AG Bajpayee","year":"2017","unstructured":"Bajpayee, A. G. & Grodzinsky, A. J. Cartilage-targeting drug delivery: can electrostatic interactions help? Nat. Rev. Rheumatol. 13, 183\u2013193 (2017).","journal-title":"Nat. Rev. Rheumatol."},{"key":"25697_CR58","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1089\/hum.2017.181","volume":"29","author":"CH Evans","year":"2018","unstructured":"Evans, C. H., Ghivizzani, S. C. & Robbins, P. D. Gene delivery to joints by intra-articular injection. Hum. Gene Ther. 29, 2\u201314 (2018).","journal-title":"Hum. Gene Ther."},{"key":"25697_CR59","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1093\/hmg\/ddm353","volume":"17","author":"S Tomatsu","year":"2008","unstructured":"Tomatsu, S. et al. Enzyme replacement therapy in a murine model of Morquio A syndrome. Hum. Mol. Genet. 17, 815\u2013824 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"25697_CR60","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/mt.2011.220","volume":"20","author":"A Ruzo","year":"2012","unstructured":"Ruzo, A. et al. Liver production of sulfamidase reverses peripheral and ameliorates CNS pathology in mucopolysaccharidosis IIIA mice. Mol. Ther. 20, 254\u2013266 (2012).","journal-title":"Mol. Ther."},{"key":"25697_CR61","doi-asserted-by":"crossref","unstructured":"Puzzo, F. et al. Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid \u03b1-glucosidase. Sci. Transl. Med. 9, eaam6375 (2017).","DOI":"10.1126\/scitranslmed.aam6375"},{"key":"25697_CR62","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nature06902","volume":"453","author":"KL Spalding","year":"2008","unstructured":"Spalding, K. L. et al. Dynamics of fat cell turnover in humans. Nature 453, 783\u2013787 (2008).","journal-title":"Nature"},{"key":"25697_CR63","first-page":"17","volume":"62","author":"U White","year":"2019","unstructured":"White, U. & Ravussin, E. Dynamics of adipose tissue turnover in human metabolic health and disease HHS public access. Physiol. Behav. 62, 17\u201323 (2019).","journal-title":"Physiol. Behav."},{"key":"25697_CR64","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1128\/JVI.75.15.6969-6976.2001","volume":"75","author":"H Nakai","year":"2001","unstructured":"Nakai, H. et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969\u20136976 (2001).","journal-title":"J. Virol."},{"key":"25697_CR65","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/mt.2011.151","volume":"19","author":"L Wang","year":"2011","unstructured":"Wang, L. et al. AAV8-mediated hepatic gene transfer in infant rhesus monkeys (Macaca mulatta). Mol. Ther. 19, 2012\u20132020 (2011).","journal-title":"Mol. Ther."},{"key":"25697_CR66","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1089\/hum.2011.183","volume":"23","author":"L Wang","year":"2012","unstructured":"Wang, L., Wang, H., Bell, P., McMenamin, D. & Wilson, J. M. Hepatic gene transfer in Neonatal mice by Adeno-associated virus serotype 8 vector. Hum. Gene Ther. 23, 533\u2013539 (2012).","journal-title":"Hum. Gene Ther."},{"key":"25697_CR67","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1089\/hum.2013.233","volume":"25","author":"G Bortolussi","year":"2014","unstructured":"Bortolussi, G. et al. Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar syndrome. Hum. Gene Ther. 25, 844\u2013855 (2014).","journal-title":"Hum. Gene Ther."},{"key":"25697_CR68","first-page":"87","volume":"8","author":"P Colella","year":"2018","unstructured":"Colella, P., Ronzitti, G. & Mingozzi, F. Emerging issues in AAV-mediated in vivo gene therapy. Mol. Ther. 8, 87\u2013104 (2018).","journal-title":"Mol. Ther."},{"key":"25697_CR69","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/mt.2010.257","volume":"19","author":"G Cotugno","year":"2011","unstructured":"Cotugno, G. et al. Long-term amelioration of feline mucopolysaccharidosis VI after AAV-mediated liver gene transfer. Mol. Ther. 19, 461\u2013469 (2011).","journal-title":"Mol. Ther."},{"key":"25697_CR70","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/14712598.2020.1817375","volume":"21","author":"P Piccolo","year":"2020","unstructured":"Piccolo, P., Rossi, A. & Brunetti-Pierri, N. Liver-directed gene-based therapies for inborn errors of metabolism. Expert Opin. Biol. Ther. 21, 229\u2013240 (2020).","journal-title":"Expert Opin. Biol. Ther."},{"key":"25697_CR71","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/156652310793797685","volume":"10","author":"E Ayuso","year":"2010","unstructured":"Ayuso, E., Mingozzi, F. & Bosch, F. Production, purification and characterization of adeno-associated vectors. Curr. Gene Ther. 10, 423\u2013436 (2010).","journal-title":"Curr. Gene Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25697-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25697-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T02:56:08Z","timestamp":1725764168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25697-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25697"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25697-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"27 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.B., V.S., M.G., A.P., and F.B. are co-inventors on a patent application for the use of the animal model for MPSIVA. V.S., A.R., and F.B. are co-inventors on a patent application for the use of AAV vectors for the treatment of MPSIVA. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5343"}}